Los nuevos reactivos Aptiva APS IgG y APS IgM permiten el diagnóstico temprano del síndrome antifosfolípido en enfermedades autoinmunes difíciles de diagnosticar SAN DIEGO, 19 de febrero de 2024 /PRNewswire/ — Werfen anunció hoy que ha recibido la marca CE (Conformité Européenne) para…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.